Entera Bio Ltd (ENTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENTX | BMY | AMGN | GILD | REGN |
| Company | Entera Bio Ltd | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.8400 | 65.34 | 221.26 | 75.76 | 736.96 |
| High | 0.8800 | 65.61 | 221.88 | 78.46 | 751.23 |
| Low | 0.8050 | 65.07 | 219.36 | 75.76 | 736.96 |
| Last | 0.8051 | 65.31 | 220.76 | 78.40 | 750.12 |
| Change | +0.0049 | +0.15 | -0.49 | +2.32 | +11.49 |
| % Change | +0.61% | +0.23% | -0.22% | +3.05% | +1.56% |
| Volume | 5,173 | 4,995,423 | 1,877,256 | 8,860,354 | 359,362 |
| 20-Day Average Volume | 38,699 | 8,343,171 | 2,562,893 | 5,548,798 | 519,118 |
| Previous Close | 0.8002 | 65.16 | 221.25 | 76.08 | 738.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8703 | 65.85 | 223.00 | 77.81 | 742.46 |
| 20-Day Raw Stochastic | 23.45% | 37.15% | 38.87% | 69.34% | 64.17% |
| 20-Day Relative Strength | 45.21% | 43.11% | 40.21% | 47.74% | 47.36% |
| Weighted Alpha | -66.35 | -14.80 | -12.70 | +21.71 | +20.00 |
| Today's Opinion | 72% Sell | 100% Sell | 100% Sell | 56% Sell | 8% Buy |
| Previous Opinion | 72% Sell | 100% Sell | 100% Sell | 72% Sell | 24% Sell |
| Last Month's Opinion | 40% Sell | 88% Sell | 88% Sell | 24% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.26% since 06/01/23 | +0.97% since 06/01/23 | +3.03% since 06/01/23 | +2.87% since 06/01/23 | +2.59% since 06/01/23 |
| Low | 0.7851 on 06/06/23 | 64.49 on 06/02/23 | 212.02 on 06/02/23 | 75.12 on 06/07/23 | 724.12 on 06/02/23 |
| High | 0.9000 on 06/05/23 | 66.46 on 06/05/23 | 223.17 on 06/06/23 | 78.46 on 06/08/23 | 754.50 on 06/06/23 |
| 1-Month | |||||
| %Chg | -8.51% since 05/08/23 | -4.53% since 05/08/23 | -5.91% since 05/08/23 | -0.24% since 05/08/23 | -0.27% since 05/08/23 |
| Low | 0.7301 on 05/25/23 | 63.07 on 05/30/23 | 211.71 on 06/01/23 | 75.12 on 06/07/23 | 717.88 on 05/30/23 |
| High | 1.0499 on 05/15/23 | 69.10 on 05/11/23 | 235.43 on 05/09/23 | 79.85 on 05/22/23 | 768.12 on 05/22/23 |
| 3-Month | |||||
| %Chg | -38.07% since 03/08/23 | -2.94% since 03/08/23 | -3.36% since 03/08/23 | -2.24% since 03/08/23 | +0.66% since 03/08/23 |
| Low | 0.6800 on 04/26/23 | 63.07 on 05/30/23 | 211.71 on 06/01/23 | 75.12 on 06/07/23 | 717.88 on 05/30/23 |
| High | 1.3900 on 03/29/23 | 71.07 on 04/06/23 | 256.44 on 04/10/23 | 87.37 on 04/24/23 | 837.55 on 04/05/23 |
| 6-Month | |||||
| %Chg | +29.83% since 12/08/22 | -18.24% since 12/08/22 | -22.69% since 12/08/22 | -12.37% since 12/08/22 | -2.00% since 12/08/22 |
| Low | 0.5200 on 12/23/22 | 63.07 on 05/30/23 | 211.71 on 06/01/23 | 75.12 on 06/07/23 | 668.00 on 01/09/23 |
| High | 1.4800 on 03/06/23 | 80.67 on 12/09/22 | 285.17 on 12/09/22 | 89.74 on 12/13/22 | 837.55 on 04/05/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 23,049 | 136,891,184 | 118,219,848 | 94,898,624 | 80,751,456 |
| Shares Outstanding, K | 28,804 | 2,100,847 | 534,327 | 1,247,353 | 109,326 |
| Annual Sales | 130,000 | 46,159,000,000 | 26,323,000,000 | 27,281,000,000 | 12,172,900,000 |
| Annual Net Income | -13,070,000 | 6,327,000,000 | 6,552,000,000 | 4,592,000,000 | 4,338,400,000 |
| Last Quarter Sales | 10,000 | 11,337,000,000 | 6,105,000,000 | 6,352,000,000 | 3,162,100,000 |
| Last Quarter Net Income | -3,040,000 | 2,262,000,000 | 2,841,000,000 | 1,011,000,000 | 817,800,000 |
| 60-Month Beta | 1.82 | 0.44 | 0.64 | 0.39 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 05/05/23 | 2.05 on 04/27/23 | 3.98 on 04/27/23 | 1.37 on 04/27/23 | 10.09 on 05/04/23 |
| Latest Earnings Date | 05/11/23 | 07/27/23 | 04/27/23 | 08/01/23 | 05/04/23 |
| Most Recent Dividend | N/A | 0.570 on 04/06/23 | 2.130 on 05/17/23 | 0.750 on 03/14/23 | N/A |
| Next Ex-Dividends Date | N/A | 04/06/23 | 05/17/23 | 06/14/23 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 8.41 | 12.70 | 11.69 | 19.11 |
